350 rub
Journal №6 for 2013 г.
Article in number:
Mechanisms of development and ways to overcome the resistance of different medicaments
Keywords: drug resistance antibiotics antiviral antifungal and antiprotozoal drugs
Authors:
E.V. Goltseva
Abstract:
This article discusses general regularities of the development of resistance to various types of medicaments used for treatment of diseases caused by viruses and pathogenic microorganisms. The article also shows the mechanisms of action of the most common classes of drugs and the possible ways to overcome drug resistance.
Pages: 7-9
References

  1. Sidorenko S.V. Mexanizmy' rezistentnosti mikroorganizmov / V kn.: Prakticheskoe rukovodstvo po antiinfekczionnoj ximioterapii / pod red. L.S. Strachunskogo, Ju.B. Belousova, S.N. Kozlova. 2002. NIIAX SGMA. S. 31-48.
  2. Supotniczkij M.V. Mexanizmy' razvitiya rezistentnosti k antibiotikam u bakterij // Biopreparaty'. 2011. № 2. S. 4-11.
  3. Hawkey P.M. The origins and molecular basis of antibiotic resistance // BMJ. 1998. V. 317. № 7159. S. 657-60.
  4. Fluit A.C., Visser M.R., Schmitz F.J. Molecular detection of antimicrobial resistance // Clin Microbiol Rev. 2001. V. 14. № 4. S. 836-871.
  5. Livermore D.M. Veta-lactamases in laboratory and clinical resistance // Clin. Microbiol. Rev. 1995. V. 8. № 4. S. 557-584.
  6. Shaw K.J., Rather P.N., Hare R.S., Miller G.H. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes // Microbiol. Rev. 1993. V. 57. № 1. C. 138-163.
  7. Schnappinger D., Hillen W. Tetracyclines: antibiotic action, uptake, and resistance mechanisms // Arch. Microbiol. 1996. V. 165. № 6. C. 359-369.
  8. Leclercq R., Courvalin P. Resistance to glycopeptides in enterococci // Clin .Infect. Dis. 1997. V. 24. № 4. C. 545-54.
  9. Raymund R. Razonable. Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus // Mayo Clin. Proc. 2011. V. 86. № 10. S. 1009-1026.
  10. Kravchenko A.V., Rafal'skij V.V. Antiretrovirusny'e ximiopreparaty' / V kn.: Prakticheskoe rukovodstvo po antiinfekczionnoj ximioterapii / pod red. L.S. Strachunskogo, Ju.B. Belousova, S.N. Kozlova. 2002. NIIAX SGMA. S. 254-276
  11. De Clercq E. Antiviral drugs in current clinical use // J. Clin. Virol. 2004. V. 30. № 2. S. 115-133.
  12. Esposito F., Corona A., Tramontano E. HIV-1 Reverse Transcriptase Still Remains a New Drug Target: Structure, Function, Classical Inhibitors, and New Inhibitors with Innovative Mechanisms of Actions // Mol. Biol. Int. 2012. doi: 10.1155/2012. 586401.
  13. Nell S. Lurain, Sunwen Chou. Antiviral Drug Resistance of Human Cytomegalovirus // Clin. Microbiol. Rev. 2010. V. 23. № 4. S. 689-712.
  14. Strachunskij L.S. Protivogerpeticheskie ximiopreparaty' / V kn.: Prakticheskoe rukovodstvo po antiinfekczionnoj ximioterapii / pod red. L.S. Strachunskogo, Ju.B. Belousova, S.N. Kozlova. 2002. NIIAX SGMA. S. 229-237.
  15. Strachunskij L.S. Protivoczitomegalovirusny'e ximiopreparaty' / V kn.: Prakticheskoe rukovodstvo po antiinfekczionnoj ximioterapii / pod red. L.S. Strachunskogo, Ju.B. Belousova, S.N. Kozlova. 2002. NIIAX SGMA. S. 237-240.
  16. Moss R.B., Davey R.T., Steigbigel R.T., Fang F. Targeting pandemic influenza: a primer on influenza antivirals and drug resistance // J. Antimicrob. Chemother. 2010. V. 65. № 6. S. 1086-1093.
  17. Kozlov S.N. Protivogrippozny'e ximiopreparaty' / V kn.: Prakticheskoe rukovodstvo po antiinfekczionnoj ximioterapii / pod red. L.S. Strachunskogo, Ju.B. Belousova, S.N. Kozlova. 2002. NIIAX SGMA. S. 240-246.
  18. Marcellin P., Asselah T., Boyer N. Treatment of chronic hepatitis B // J. Viral. Hepat. 2005. V. 12. № 4. S. 333-345.
  19. Gish R.G. Treating HCV with ribavirin analogues and ribavirin-like molecules // J. Antimicrob. Chemother. 2006. V. 57. № 1. S. 8-13.
  20. Rafal'skij V.V. Protivovirusny'e ximiopreparaty' rasshirennogo spektra / V kn.: Prakticheskoe rukovodstvo po antiinfekczionnoj ximioterapii / pod red. L.S. Strachunskogo, Ju.B. Belousova, S.N. Kozlova. 2002. NIIAX SGMA. S. 246-254.
  21. Christopher J. De Feo, Carol D. Weiss. Escape from Human Immunodeficiency Virus Type 1 (HIV-1) Entry Inhibitors // Viruses. 2012. V. 4. № 12. S. 3859-3911.
  22. Leneva I.A., Russell R.J., Boriskin Y.S., Hay A.J. Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol // Antiviral Res. 2009. V. 81. № 2. C. 132-140.
  23. Mahmoud A. Ghannoum, Louis B. Rice. Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance // Clin. Microbiol Rev. 1999. V. 12. № 4. S. 501-517.
  24. Sheehan D.J., Hitchcock Ch.A., Sibley C.M. Current and Emerging Azole Antifungal Agents // Clin. Microbiol. Rev. 1999. V. 12. № 1. S. 40-79.
  25. Ryder N.S., Seidl G., Troke P.F. Effect of the Antimycotic Drug Naftifine on Growth of and Sterol Biosynthesis in Candida albicans // Antimicrob. Agents. Chemother. 1984. V. 25. № 4. S. 483-487.
  26. Morris M.I., Villmann M. Echinocandins in the management of invasive fungal infections, part 1 // Am. J. Health. Syst. Pharm. 2006. V. 63. № 18. S. 1693-1703.
  27. Vermes A., Guchelaar H.J., Dankert J. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions // J. Antimicrob. Chemother. 2000. V. 46. № 2. S. 171-179.
  28. Chandrasekar P. Management of invasive fungal infections: a role for polyenes // J. Antimicrob. Chemother. 2011. V. 66. № 3. S. 457-465
  29. Chelsea Marie, Theodore C. White. Genetic Basis of Antifungal Drug Resistance // Curr. Fungal. Infect. Rep. 2009. V. 3. № 3. S. 163-169.
  30. Tokmalaev A.K., Maleev V.V. Protivoprotozojny'e ximiopreparaty' / V kn.: Prakticheskoe rukovodstvo po antiinfekczionnoj ximioterapii / pod red. L.S. Strachunskogo, Ju.B. Belousova, S.N. Kozlova. 2002. NIIAX SGMA. S. 276-304.
  31. Fidock D.A., Eastman R.T., Ward S.A., Meshnick S.R. Recent highlights in antimalarial drug resistance and chemotherapy research // Trends Parasitol. 2008. V. 24. № 12. C. 537-544.
  32. Upcroft P., Upcroft J.A. Drug targets and mechanisms of resistance in the anaerobic protozoa // Clin. Microbiol. Rev. 2001. V. 14. № 1. C. 150-164.
  33. Roepe P.D. PfCRT-mediated drug transport in malarial parasites // Biochemistry. 2011. V. 50. № 2. C. 163-171.